[Coronary artery bypass graft in adolescent suffering from homozygous familial hypercholesterolemia resistant to probucol therapy].
Homozygous familial hypercholesterolemia is a rare hypercholesterolemia representing 1 to 2% of hypercholesterolemia. It is a metabolic disorder coming from genetic trouble with a bad prognostic. Its probucol's therapy in an adolescent is subject of controversy. The authors report a new case diagnosed in an adolescent of 15-year-old followed after CABG in the Thoracic and cardiovascular surgery Department of National Heart Institute Imbaba-Cairo (Egypt).
Ayegnon
Kouakou Grégoire
KG
Département de Chirurgie Thoracique et Cardiovasculaire, CHU de Bouaké, Côte d'Ivoire. ayekouakougreg@yahoo.fr
Morcos
Kamel Karim
KK
Yangni-Angate
Koffi Hervé
KH
Ahmed-Nasr
Mohamed
M
D000293:Adolescent; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D004351:Drug Resistance; D006720:Homozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D011341:Probucol / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D011341:Probucol